TransMedics Reports Third Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Bel Fuse acquires dataMate ethernet business for $16 million
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
TransMedics (TMDX) surges 40% after raising sales forecast
November 7, 2023 6:53 AM ESTTransMedics Group (NASDAQ: TMDX) saw its stock rise more than 40% in pre-market Tuesday trading after the organ transplant company raised its full-year sales forecast.
In addition to the improved outlook, the health-care firm reported third-quarter revenue that exceeded the average analyst... More
TransMedics Group (TMDX) surges 30% on strong revenue beat and guidance
November 6, 2023 4:21 PM ESTTransMedics Group (NASDAQ: TMDX) surges after strong Q3 revenue beat and raised FY revenue guidance:
reported Q3 EPS of ($0.78), $0.62 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $66.4 million versus the consensus estimate of $49.19 million.sees FY 2023... MoreTransMedics Group (TMDX) Q3 Revenue Beat; Raises FY Revenue Guidance
November 6, 2023 4:20 PM ESTTransMedics Group (NASDAQ: TMDX) reported Q3 EPS of ($0.78), $0.62 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $66.4 million versus the consensus estimate of $49.19 million.
GUIDANCE:
TransMedics Group sees FY2023 revenue of $222-230 million, versus prior of... More
